BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24350847)

  • 1. Synergy against fungal pathogens: working together is better than working alone.
    Musiol R; Mrozek-Wilczkiewicz A; Polanski J
    Curr Med Chem; 2014 Mar; 21(7):870-93. PubMed ID: 24350847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
    Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
    Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal adjuvants: Preserving and extending the antifungal arsenal.
    Butts A; Palmer GE; Rogers PD
    Virulence; 2017 Feb; 8(2):198-210. PubMed ID: 27459018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Stress Response Pathways with Alternative Strategies as a Novel Antifungal Approach.
    Ruhil S; Kumar V; Balhara M; Malik M; Chhillar AK
    Mini Rev Med Chem; 2021; 21(16):2337-2346. PubMed ID: 33749563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approaches for Efficient Antifungal Drug Action.
    Lee H; Lee DG
    J Microbiol Biotechnol; 2018 Nov; 28(11):1771-1781. PubMed ID: 30178649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Antifungal Agents: Current Status and Projected Future Developments.
    Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
    Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole antimycotics--a highway to new drugs or a dead end?
    Musiol R; Kowalczyk W
    Curr Med Chem; 2012; 19(9):1378-88. PubMed ID: 22257053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.
    Parente-Rocha JA; Bailão AM; Amaral AC; Taborda CP; Paccez JD; Borges CL; Pereira M
    Mediators Inflamm; 2017; 2017():9870679. PubMed ID: 28694566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential targets for the development of new antifungal drugs.
    Su H; Han L; Huang X
    J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antifungal therapy: the new frontier.
    Vazquez JA
    Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal peptides: potential candidates for the treatment of fungal infections.
    De Lucca AJ
    Expert Opin Investig Drugs; 2000 Feb; 9(2):273-99. PubMed ID: 11060677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity.
    Wall G; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling Fungal Resistance by Biofilm Inhibitors.
    Wu S; Wang Y; Liu N; Dong G; Sheng C
    J Med Chem; 2017 Mar; 60(6):2193-2211. PubMed ID: 28051303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics as antifungal agents: Experimental confirmation and future prospects.
    Kosgey JC; Jia L; Fang Y; Yang J; Gao L; Wang J; Nyamao R; Cheteu M; Tong D; Wekesa V; Vasilyeva N; Zhang F
    J Microbiol Methods; 2019 Jul; 162():28-37. PubMed ID: 31071354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.